SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-249120
Filing Date
2020-09-18
Accepted
2020-09-18 16:16:20
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d15037d10q.htm 10-Q 962659
2 EX-31.1 d15037dex311.htm EX-31.1 9928
3 EX-31.2 d15037dex312.htm EX-31.2 9937
4 EX-32.1 d15037dex321.htm EX-32.1 4731
5 EX-32.2 d15037dex322.htm EX-32.2 4812
  Complete submission text file 0001193125-20-249120.txt   4534454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cmpi-20200630.xml EX-101.INS 851228
7 XBRL TAXONOMY EXTENSION SCHEMA cmpi-20200630.xsd EX-101.SCH 45297
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpi-20200630_cal.xml EX-101.CAL 19449
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpi-20200630_def.xml EX-101.DEF 226072
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpi-20200630_lab.xml EX-101.LAB 333781
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpi-20200630_pre.xml EX-101.PRE 297030
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39425 | Film No.: 201184184
SIC: 2836 Biological Products, (No Diagnostic Substances)